Michael Byrnes

Chief Financial Officer at Ocera Therapeutics Inc

Michael Byrnes's Professional Contact Details

Email (Verified)

****@ocerainc.com

Get Email Address

(650) 475-0158

Location

San Francisco, California, US

Company

Ocera Therapeutics Inc

Person Seniority

c_suite

Person Functions

finance

Michael Byrnes's Current Company Details

Ocera Therapeutics Inc

Redwood City, California, US • 17 Employees

biotechnology

Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of OCR-002 (ornithine phenylacetate) in both intravenous and oral formulations. OCR-002 is an ammonia scavenger and has been granted orphan drug designation and Fast Track status by the U.S. Food and Drug Administration (FDA) for the treatment of hyperammonemia and resultant hepatic encephalopathy in patients with acute liver failure and acute-on-chronic liver disease. For additional information, please see www.ocerainc.com. We offer a competitive compensation and comprehensive benefits package including medical, dental, vision, life and disability insurance, a 401(k) plan and optional flexible spending accounts plus paid-time off and company holidays.

Founded Year

2005

Organization Website

ocerainc.com

Organization Revenue

13000

Current Technologies

outlook

google analytics

wordpress org

asp net

nginx